Cannapharmarx Inc (CPMD)
0.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Cannapharmarx 1 Year Total Returns (Daily): 8.70% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 8.70% |
| May 02, 2024 | 0.00% |
| May 01, 2024 | 0.00% |
| April 30, 2024 | 0.00% |
| April 29, 2024 | 0.00% |
| April 26, 2024 | 0.00% |
| April 25, 2024 | 8.11% |
| April 24, 2024 | -2.44% |
| April 23, 2024 | -9.09% |
| April 22, 2024 | -9.09% |
| April 19, 2024 | -4.76% |
| April 18, 2024 | -4.76% |
| April 17, 2024 | 0.00% |
| April 16, 2024 | 48.72% |
| April 15, 2024 | 53.85% |
| April 12, 2024 | 59.09% |
| April 11, 2024 | 82.35% |
| April 10, 2024 | 76.14% |
| April 09, 2024 | 59.14% |
| April 08, 2024 | 97.52% |
| April 05, 2024 | 136.1% |
| April 04, 2024 | 47.37% |
| April 03, 2024 | 77.78% |
| April 02, 2024 | 90.56% |
| April 01, 2024 | 105.6% |
| Date | Value |
|---|---|
| March 28, 2024 | 34.55% |
| March 27, 2024 | 96.67% |
| March 26, 2024 | 50.00% |
| March 25, 2024 | 71.82% |
| March 22, 2024 | 51.26% |
| March 21, 2024 | 70.00% |
| March 20, 2024 | 39.60% |
| March 19, 2024 | 50.50% |
| March 18, 2024 | 18.81% |
| March 15, 2024 | 50.60% |
| March 14, 2024 | 92.31% |
| March 13, 2024 | 98.72% |
| March 12, 2024 | 76.47% |
| March 11, 2024 | 85.29% |
| March 08, 2024 | 129.4% |
| March 07, 2024 | 166.7% |
| March 06, 2024 | 130.8% |
| March 05, 2024 | 92.31% |
| March 04, 2024 | 66.67% |
| March 01, 2024 | 29.87% |
| February 29, 2024 | 34.15% |
| February 28, 2024 | 34.15% |
| February 27, 2024 | 12.36% |
| February 26, 2024 | 12.36% |
| February 23, 2024 | 1.14% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.92%
Minimum
Aug 17 2021
594.0%
Maximum
Apr 20 2021
-39.21%
Average
-57.50%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 10.17% |
| Aurinia Pharmaceuticals Inc | -56.37% |
| Edesa Biotech Inc | -40.91% |
| Lexaria Bioscience Corp | 93.21% |
| Xenon Pharmaceuticals Inc | 7.28% |